Vicier C, Sfumato P, Isambert N, Dalenc F, et al. TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. Eur J Cancer 2021;159:205-214.
PMID: 34781168